WHO green­lights Takeda's dengue vac­cine as com­pa­ny plans to 're-en­gage' with FDA

The World Health Or­ga­ni­za­tion pre­qual­i­fied Take­da’s new dengue vac­cine on Wednes­day, a year af­ter the com­pa­ny with­drew its FDA ap­pli­ca­tion for the can­di­date — though the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER